The leading market experts have placed a mean price target of $24.44 on Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.57 a share for the upcoming quarter and $2.28 for the current fiscal.
The technical analysis of Sabra Healthcare REIT, Inc. plainly substantiates that the 50-day moving average of Sabra Healthcare REIT, Inc. is $23.48, and stock is trading $1.42 points away or +6.04% from its 50-day moving average of $23.48. Further it is trading $3.82 or +18.10% away its 200-day moving average of $21.08. Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) 52-week high is $25.90 and the 52-week low is $14.92.
This explains if the stock moves $-1.00, it will post a 52-week high. In event of +66.89% decline, a 52-week low will be hit.
Taking the valuation aspect to emphasize the valuation of Sabra Healthcare REIT, Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) ratio came in at 29.75.
The stock last ended the trading session at $24.90 and registered a market cap of $1.63B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) PEG ratio is at 4.57.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...